New FDA Cybersecurity Requirements: What MedTech Companies Need to Know

The FDA's recent cybersecurity guidance represents a fundamental shift in how medical device manufacturers must approach security throughout the product lifecycle. With cyber threats to healthcare infrastructure increasing in sophistication and frequency, regulatory expectations have evolved significantly.

What's Changed

The FDA's updated guidance, effective since March 2024, introduces several critical requirements:

1. Cybersecurity Bill of Materials (CBOM)

Medical device manufacturers must now provide a comprehensive CBOM that includes:

• All software components and their versions
• Known vulnerabilities and mitigation strategies
• Third-party software dependencies
• Open-source components and their licenses

2. Secure Product Development Framework (SPDF)

Devices must be developed using a secure development lifecycle that includes:

• Threat modeling during design phase
• Security testing throughout development
• Vulnerability management processes
• Incident response capabilities

3. Software Bill of Materials (SBOM)

Beyond the CBOM, an SBOM must detail:

• All software components
• Dependency relationships
• Known security vulnerabilities
• Update and patch management procedures

Why This Matters for MedTech Startups

For startups, these requirements represent both a challenge and an opportunity:

The Challenge

Implementing comprehensive cybersecurity measures requires:

• Dedicated security expertise (often requiring new hires or consultants)
• Additional development time and costs
• Ongoing monitoring and update capabilities
• Documentation and validation processes

The Opportunity

Companies that excel at cybersecurity can:

• Differentiate themselves in the market
• Build stronger relationships with healthcare IT departments
• Reduce long-term liability and risk
• Accelerate regulatory approvals by demonstrating proactive compliance

Practical Implementation Steps

Phase 1: Assessment (Months 1-2)

1. Conduct Security Risk Assessment: Identify all potential cybersecurity risks to your device
2. Review Current Practices: Evaluate existing development and security processes against FDA expectations
3. Identify Gaps: Determine what additional capabilities, processes, or expertise you need

Phase 2: Framework Development (Months 3-4)

1. Establish SPDF: Implement secure development practices aligned with NIST or IEC 62443 standards
2. Create CBOM/SBOM Processes: Develop systems for tracking and documenting all software components
3. Define Vulnerability Management: Establish procedures for identifying, assessing, and addressing vulnerabilities

Phase 3: Implementation (Months 5-8)

1. Integrate Security Testing: Build security testing into your development pipeline
2. Develop Update Mechanisms: Create secure, validated processes for deploying patches and updates
3. Train Your Team: Ensure all team members understand their role in maintaining device security

Phase 4: Validation and Documentation (Months 9-12)

1. Conduct Security Testing: Perform penetration testing and vulnerability assessments
2. Document Everything: Create comprehensive documentation of your cybersecurity approach
3. Establish Monitoring: Implement post-market surveillance for security issues

Common Pitfalls to Avoid

Treating Cybersecurity as a Checkbox Exercise: The FDA expects ongoing commitment to security, not just compliance at submission time.

Underestimating Resource Requirements: Budget for dedicated security expertise—it's not something your software developers can handle part-time.

Ignoring Third-Party Components: Your security is only as strong as your weakest dependency. Thoroughly vet all third-party software.

Neglecting Post-Market Surveillance: Plan for how you'll monitor, detect, and respond to security issues after your device is in the field.

Integration with Quality Management Systems

Cybersecurity requirements must be integrated into your existing QMS:

• Design Controls: Include security requirements in design inputs and verification
• Risk Management: Expand risk analysis to include cybersecurity threats
• CAPA: Establish processes for addressing security vulnerabilities
• Supplier Management: Ensure suppliers meet cybersecurity expectations

Looking Forward

The FDA has signaled that cybersecurity requirements will continue to evolve. Stay ahead by:

• Monitoring FDA guidance updates and industry best practices
• Participating in industry working groups (e.g., MDCG, IMDRF)
• Building relationships with cybersecurity experts
• Investing in security infrastructure early

The Bottom Line

While the new cybersecurity requirements add complexity to medical device development, they're ultimately about protecting patients and healthcare systems. Companies that embrace these requirements as part of their quality culture—rather than viewing them as regulatory burdens—will be better positioned for long-term success.

Need help navigating FDA cybersecurity requirements? Our team can help you develop a comprehensive cybersecurity strategy that meets regulatory expectations while fitting your startup's resources and timeline.